SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec informs about shares dematerialized

06 Sep 2023 Evaluate

With reference to CDSL’s Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, Panacea Biotec has informed that it enclosed the data of shares dematerialized during the month of August, 2023 as Annexure - 1. The company has confirmed that the total number of shares dematerialized as on August 31, 2023, were as: NSDL 5,45,07,156: CDSL 65,64,359 = Total 6,10,71,515. A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services regarding shares dematerialized as on August 31, 2023 is also enclosed as Annexure -2.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

356.80 -6.60 (-1.82%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×